DKN-01 in combination with tislelizumab and chemotherapy as a first-line therapy in unselected patients with advanced gastroesophageal adenocarcinoma (GEA): DisTinGuish trial Meeting Abstract

International Collaboration

cited authors

  • Klempner, S. J.; Sirard, C.; Chao, J.; Chiu, V.; Mahalingam, D.; Uronis, H.; Kagey, M.; Baum, J.; Dayyani, F.; Song, J.; Wang, J.; Iqbal, S.; Tejani, M.; Sonbol, M. B.; Scott, A. J.; Wainberg, Z.; Ajani, J. A.

authors

Publication Date

  • January 1, 2021

webpage

published in

category

start page

  • S1048

end page

  • S1049

volume

  • 32